A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

A. Pfeffer, Marc; A. Burdmann, Emmanuel; Yin Chen, Chao; E. Cooper, Mark; de Zeeuw, Dick; Eckardt, Kai-Uwe; Feyzi, Jan; Ivanovich, Peter; Kewalramani, Reshma; S. Levey, Andrew; F. Lewis, Eldrin; B. McGill, Janet; J.V. McMurray, John; S. Parfrey, Patrick; Henrik Parving, Hans; Remuzzi, Giuseppe; Singh, Ajay; D. Solomon, Scott; D. Toto, Robert

doi:10.1056/nejmoa0907845

Public

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Published in New England Journal of Medicine • Oct 30, 2009

Authors:

Marc A. Pfeffer

Emmanuel A. Burdmann

Chao Yin Chen

Abstract

BACKGROUND: Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately t...

Subject

Medicine

Darbepoetin alfa

Kidney disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!